Factor | Multivariate analysis | ||
---|---|---|---|
Hazard ratio [95% confidence interval] | P | ||
Age | 1.031 [0.881, 1.207] | 0.701 | |
Race | 0.449 [0.074, 2.715] | 0.383 | |
T stage | 0.178 [0.005, 6.126] | 0.339 | |
Grade (Gleason score) | 2.771 [0.794, 9.663] | 0.110 | |
Margins | 0.181 [0.003, 10.732] | 0.412 | |
Seminal vesicle inv. | 0.405 [0.406, 4.034] | 0.441 | |
ECE | 0.930 [0.057, 14.951] | 0.959 | |
Post-RRP PSA nadir | 1.289 [0.485, 3.421] | 0.611 | |
Highest post-RRP PSA | 0.911 [0.359, 2.310] | 0.845 | |
RRP-to-RT interval | 1.004 [0.999, 1.008] | 0.096 | |
Treatment technique | 1.762 [0.250, 12.393] | 0.569 | |
Final RT dose | 0.998 [0.994, 1.001] | 0.194 | |
Hormone therapy | 8.836 [0.023, 3,268.082] | 0.470 | |
RIS scan | 1.209 [0.030, 48.349] | 0.920 | |
RIS/CT correlation | 0.010 [0.0001, 0.848] | 0.042 |
inv. = invasion.